Have an account? Log in.
I don't have an account.
According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.
https://www.shionogi.com/global/en/news/2026/04/20260401_12.html
https://www.gsk.com/en-gb/media/press-releases/exdensur-depemokimab-approved-in-china-for-the-treatment-of-severe-asthma/
AnaptysBio, Inc. (Nasdaq: ANAB) today announced that its Board of Directors has authorized a Stock Repurchase Plan under which the company may repurchase up to $100,000,000 of the company's outstanding common stock, par
Submission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials.Nearly 3.2 million people in Europe live with chronic hepatitis B (CHB), a leading cause of
The Starter plan only unlocks analyses for the 25 stocks tracked over the past month. With the Compact plan, you get access to all stocks from Germany and the USA – with Premium, worldwide access.